Merck initiates three Phase III trials into Keytruda for prostate cancer
As a result of promising data from its Phase Ib/II KEYNOTE-365 trial, Merck has announced three new Phase III trials...
Focus:
-
![SK Biopharmaceuticals-Arvelle partner on epilepsy drug cenobamate in Europe]()
SK Biopharmaceuticals-Arvelle partner on epilepsy drug cenobamate in Europe
-
![Erectile dysfunction: giving patients more choice and better treatments]()
Erectile dysfunction: giving patients more choice and better treatments
-
![AbCellera and Novartis enter into multi-target partnership]()
AbCellera and Novartis enter into multi-target partnership
-
![National Heart Month: how can you heal a broken heart?]()
National Heart Month: how can you heal a broken heart?
-
![MHRA recalls a further three batches of sartan-based products]()
MHRA recalls a further three batches of sartan-based products
-
![Dementia Consortium welcomes new partners to drug discovery collaboration]()
Dementia Consortium welcomes new partners to drug discovery collaboration
Expert commentary & analysis from GlobalData
The world is getting better, look no further than vaccines
AstraZeneca hopes FDA breakthrough therapy can rise above a string of recent failures
Eli Lilly poised to shake-up atopic dermatitis market with first oral treatment
Checkered data hinders Reata’s bardoxolone Phase II prospects
Most Read
Company releases
Meet FPS at Events Throughout 2019
FPS has announced its presence at the following events for 2019.
AdhexPharma Industrial Factory
CMC Development
AdhexPharma’s ambition is to be recognised as the most competent and successful developer and manufacturer of transdermal (TDS), topical delivery...
Oral Thin Films
Topical Patches and Impregnated Matrix Patch (IMP)
Company whitepapers
The New ICH-GCP Revision 2016
Creative Pharma ServicesPolpharma Finished Dosage Formulation Dossier – Under Development
Polpharma B2BQualification of Equipment as Part of Process Validation for Medical Devices
anteris medicalB&W Tek OEM Catalogue
B&W TekDividella Brochure
DividellaHigh-Precision Temperature Control Solutions
Huber KältemaschinenbauPharma Application Leaflet for Diclofenac Sodium, Direct Compression
SigachiCompany A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
Medicines Manufacturing Innovation Centre, Renfrewshire
The Centre for Process Innovation (CPI), the University of Strathclyde, Scottish Enterprise, Innovate UK, AstraZeneca and GlaxoSmithKline (GSK) have partnered to open the Medicines Manufacturing...
Meissner Filtration Products’ Manufacturing Facility, Castlebar, Ireland
Eirgenix Protein Drug Production Plant
Fujifilm Diosynth Biotechnologies’ Biomanufacturing Facility Expansion
Experic’s New Manufacturing and Packaging Facility
Clinical Trials
Merck initiates three Phase III trials into Keytruda for prostate cancer
As a result of promising data from its Phase Ib/II KEYNOTE-365 trial, Merck has announced three new Phase III trials into the safety and efficacy...
AbCellera and Novartis enter into multi-target partnership
FDA grants Merck’s Keytruda priority review as first line therapy for HNSCC
ICR unveils efficacious cancer drug with new mechanism of action
Sanofi announces myeloma drug meets primary endpoint
Drug Development
FDA accepts Sarepta’s NDA for precision medicine Golodirsen
US precision medicine company Sarepta Therapeutics has announced the US Food and Drug Administration (FDA) has accepted its new drug application (NDA) for its Duchenne...
Glenmark Pharmaceuticals to establish new company in US
Canadian researchers develop molecules to reverse memory loss
SK Biopharmaceuticals-Arvelle partner on epilepsy drug cenobamate in Europe
AbCellera and Novartis enter into multi-target partnership
Market Data
Glenmark Pharmaceuticals to establish new company in US
India-based Glenmark Pharmaceuticals is set to spin-off its innovation business into a new company in the US to increase focus on innovation and advance its...
Novartis to divest Proleukin’s US rights to Clinigen for $210m
Regeneron and Sanofi cut US list price of Praluent
Pfizer recalls valsartan-containing blood pressure drug in Japan
Johnson & Johnson to disclose drug prices in television ads
Technology
CureVac withdraws from part of its RNA drug collaboration with Arcturus
US RNA-based drug discovery company Arcturus Therapeutics has resumed rights to its flagship product ARCT-810 indicated for ornithine transcarbamylase (OTC) deficiency.
Insulin delivering drug capsule could replace injections
No-deal Brexit could put UK patients at risk of fake medicines
Argenx to leverage Halozyme’s subcutaneous drug delivery technology
Merck Group granted US patent for digital-enabled supply chain security method
Go Top